Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 35.69%4.95B | 164.12%1.73B | -47.77%608.33M | 5.38%1.26B | 114.32%1.35B | -35.87%3.65B | 48.14%655.44M | -7.29%1.16B | -11.54%1.2B | -76.15%627.74M |
Net interest income | -72.39%-56.07M | -674.12%-16.13M | -176.08%-31.87M | 57.62%-7.24M | 87.64%-828K | -206.27%-32.53M | -74.36%2.81M | -202.50%-11.55M | -853.63%-17.09M | -165.83%-6.7M |
-Net interest income | 26.18%413.16M | 19.89%103.2M | 15.66%108.57M | 39.20%112.42M | 33.32%88.98M | -6.60%327.45M | 1.15%86.08M | -1.97%93.87M | 1.97%80.76M | -26.28%66.74M |
-Total interest expense | 30.35%469.23M | 43.30%119.33M | 33.23%140.44M | 22.29%119.66M | 22.28%89.81M | 12.50%359.97M | 12.31%83.27M | 24.76%105.41M | 20.82%97.85M | -8.61%73.45M |
-Interest expense for long term debt and capital securities | 30.35%469.23M | 43.30%119.33M | 33.23%140.44M | 22.29%119.66M | 22.28%89.81M | 12.50%359.97M | 12.31%83.27M | 24.76%105.41M | 20.82%97.85M | -8.61%73.45M |
Non interest income | 36.02%5B | 167.72%1.75B | -45.58%640.2M | 4.50%1.27B | 112.19%1.35B | -34.94%3.68B | 51.25%652.63M | -5.52%1.18B | -10.39%1.21B | -75.80%634.44M |
-Fees and commissions | 26.07%883.49M | 7,465.05%744.02M | -241.39%-504.52M | -37.37%241.74M | 1,361.22%402.25M | -57.36%700.8M | 72.32%-10.1M | -30.65%356.83M | 11.86%385.97M | -103.89%-31.89M |
-Other non interest income | 21.45%1.11B | 25.75%292.49M | 21.39%300.33M | 14.82%269.31M | 24.36%244.7M | 4.37%911.32M | 24.24%232.6M | 50.33%247.41M | 14.95%234.55M | -38.00%196.77M |
-Gain loss on sale of assets | 45.81%3.01B | 65.24%710.74M | 47.59%844.39M | 27.60%758.56M | 48.91%699.23M | -34.14%2.07B | 53.19%430.14M | 1.08%572.12M | -26.32%594.47M | -68.35%469.56M |
Credit losses provision | ||||||||||
Non interest expense | 5.69%4.28B | 17.57%1.06B | 3.72%1.09B | -1.15%1.05B | -1.56%1.03B | -17.84%4.05B | -3.70%898.35M | -8.94%1.05B | -16.94%1.06B | -33.50%1.04B |
Selling and administrative expenses | 4.78%3.98B | 15.88%967.95M | 4.76%1.03B | -0.11%997.31M | 0.34%984.06M | -18.34%3.8B | -6.23%835.27M | -9.52%982.39M | -17.85%998.41M | -32.72%980.77M |
-General and administrative expense | 3.08%3.15B | 10.00%761.67M | 5.02%828.6M | 0.87%786.37M | -2.68%777.76M | -17.38%3.06B | -3.20%692.44M | -9.84%788.98M | -20.76%779.56M | -29.26%799.17M |
-Selling and marketing expense | 11.86%824.04M | 44.43%206.28M | 3.68%200.53M | -3.61%210.94M | 13.60%206.3M | -22.10%736.68M | -18.58%142.82M | -8.21%193.41M | -5.48%218.84M | -44.64%181.6M |
Depreciation amortization depletion | 2.40%112.92M | 10.12%29.28M | 3.51%28.61M | 10.46%28.01M | -11.95%27.02M | 17.28%110.27M | 10.86%26.59M | 14.15%27.64M | 2.33%25.36M | 45.83%30.69M |
-Depreciation and amortization | 2.40%112.92M | 10.12%29.28M | 3.51%28.61M | 10.46%28.01M | -11.95%27.02M | 17.28%110.27M | 10.86%26.59M | 14.15%27.64M | 2.33%25.36M | 45.83%30.69M |
Other non-interest expense | 32.52%187.75M | 61.52%58.93M | -23.55%28.41M | -38.48%22M | -49.15%16.41M | -23.09%141.68M | 101.46%36.49M | -7.11%37.16M | 0.77%35.76M | -64.39%32.27M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | -19.5M | -23M | -19.5M | 0 | ||||||
Less:Other special charges | ---- | ---- | --19.5M | --23M | --19.5M | ---- | ---- | ---- | ---- | ---- |
Gain on extinguishment of debt | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | ||||||||||
Income before tax | 265.81%668.05M | 377.87%674.96M | -522.80%-497.32M | 38.79%192.04M | 171.73%298.37M | -154.31%-402.9M | 51.94%-242.91M | 10.60%117.63M | 76.23%138.37M | -139.15%-415.99M |
Income tax | 351.42%32.22M | 358.02%26.35M | -693.10%-15.9M | 1,905.24%14.12M | 269.98%7.66M | -130.53%-12.82M | 20.00%-10.21M | -73.55%2.68M | -104.17%-782K | -117.42%-4.5M |
Earnings from equity interest net of tax | ||||||||||
Net income | 263.00%635.83M | 378.74%648.61M | -518.83%-481.42M | 27.86%177.93M | 170.65%290.71M | -155.73%-390.08M | 52.77%-232.69M | 19.46%114.95M | 132.87%139.15M | -139.70%-411.48M |
Net Income continuous operations | 263.00%635.83M | 378.74%648.61M | -518.83%-481.42M | 27.86%177.93M | 170.65%290.71M | -155.73%-390.08M | 52.77%-232.69M | 19.46%114.95M | 132.87%139.15M | -139.70%-411.48M |
Minority interest income | 261.91%606.46M | 376.84%614.74M | -522.49%-459.41M | 34.10%176.63M | 169.85%274.5M | -157.32%-374.57M | 53.25%-222.06M | 21.75%108.74M | 133.78%131.71M | -139.98%-392.96M |
Net income attributable to the parent company | 289.31%29.37M | 418.49%33.87M | -454.67%-22.01M | -82.59%1.3M | 187.54%16.22M | -133.42%-15.51M | 39.63%-10.64M | -10.19%6.21M | 117.80%7.44M | -134.49%-18.52M |
Preferred stock dividends | ||||||||||
Other preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 289.31%29.37M | 418.49%33.87M | -454.67%-22.01M | -82.59%1.3M | 187.54%16.22M | -133.40%-15.51M | 39.68%-10.64M | -10.23%6.21M | 117.68%7.44M | -134.47%-18.52M |
Basic earnings per share | 275.00%0.21 | 387.50%0.23 | -420.00%-0.16 | -83.33%0.01 | 180.00%0.12 | -130.77%-0.12 | 42.86%-0.08 | -16.67%0.05 | 100.00%0.06 | -134.09%-0.15 |
Diluted earnings per share | 240.00%0.21 | 355.56%0.23 | -575.00%-0.19 | -80.00%0.01 | 168.75%0.11 | -153.57%-0.15 | 35.71%-0.09 | 0.00%0.04 | 150.00%0.05 | -140.00%-0.16 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |